Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
19
# OF OVERLAPPING
HOLDINGS
XBI
136
HOLDINGS
14%
ALSO IN IBRN
IBRN
73
HOLDINGS
38%
ALSO IN XBI
SECTOR DRIFT (XBI minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 1.8% | 5.3% | 1.8% |
 |
NEUROCRINE BIOSCIENCES INC | 1.5% | 4.5% | 1.5% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 1.5% | 4.3% | 1.5% |
|
PTC THERAPEUTICS INC | 1.3% | 4.0% | 1.3% |
|
BIOGEN IDEC INC | 1.2% | 3.7% | 1.2% |
XBI Overweight Relative to IBRN
|
TRAVERE THERAPEUTICS, INC. | 1.8% |
|
REVOLUTION MEDICINES, INC. | 1.8% |
|
TWIST BIOSCIENCE CORP. | 1.8% |
|
TG THERAPEUTICS INC | 1.7% |
|
EXELIXIS INC | 1.5% |
|
KRYSTAL BIOTECH, INC. | 1.4% |
|
APOGEE THERAPEUTICS, INC. | 1.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.3% |
|
BEAM THERAPEUTICS, INC. | 1.3% |
|
VERACYTE INC | 1.3% |
XBI Underweight Relative to IBRN
|
AXSOME THERAPEUTICS, INC. | -5.0% |
 |
ARGENX SE ADR | -4.4% |
|
ALKERMES PLC | -3.4% |
|
NEUROCRINE BIOSCIENCES INC | -3.0% |
|
EDGEWISE THERAPEUTICS, INC. | -2.9% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -2.8% |
|
PTC THERAPEUTICS INC | -2.7% |
|
CATALYST PHARMACEUTICAL PART | -2.6% |
|
SUPERNUS PHARMACEUTICALS INC | -2.6% |
|
BIOGEN IDEC INC | -2.5% |